![An In Depth Review Of Cbd Gummies Relax Nanocraftcbd [OLeO1jbOoaI]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-8670032-150x150.jpg "An In Depth Review Of Cbd Gummies Relax Nanocraftcbd [OLeO1jbOoaI] 2")
![B+cbd Gummies For Metabolic Balance And Daily Wellness [3s5LqrrZ748]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-3259579-150x150.jpg "B+cbd Gummies For Metabolic Balance And Daily Wellness [3s5LqrrZ748] 4")
![750mg Cbd Gummy Guide: Maximizing Benefits And Finding Your Perfect Dose [TDOlwAQczdj]](https://cedclinic.com/wp-content/uploads/2026/06/ced-pexels-3259596-150x150.jpg "750mg Cbd Gummy Guide: Maximizing Benefits And Finding Your Perfect Dose [TDOlwAQczdj] 24")
Teens’ Self-Reported Cannabis Use Linked to Increased Risk for New Psychiatric Diagnosis
This study highlights the association between adolescent cannabis use and new psychiatric diagnoses. The findings emphasize the need for screening cannabis use during adolescent mental health assessments. Understanding these risks is crucial for early…
Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
Youth and Cannabis: Understanding the Risks to the Adolescent Brain
Cannabis use adolescent brain risks are a growing concern as legalization expands. Clinicians face challenges counseling youth due to variable product potency and incomplete data. Understanding these risks is crucial for adolescent health and safety.
Study: Adolescent Cannabis Use Doubles Psychotic and Bipolar Disorder Risk
Adolescent cannabis psychotic risk is significantly elevated, doubling the likelihood of psychotic and bipolar disorders. This study highlights the critical neurodevelopmental vulnerability during teenage years. Clinicians should prioritize screening and…
Cannabinoids in Pediatric Care: Clinical Evidence Review
This review focuses on cannabinoid safety pediatric use, summarizing evidence from 276 studies including interventional and observational research. The clinical evidence supports cautious use of cannabinoids in pediatric medicine for select conditions.…
Mom’s Homemade Medical Cannabis Recipe Now Sold at Georgia Dispensaries
Patient-derived cannabis formulations are now being sold at Georgia dispensaries, raising important safety and quality concerns. This shift impacts pediatric autism treatment options and clinical guidance. Clinicians should stay informed about these…
Oregon Bill Failure Highlights Pediatric Cannabis Exposure Risks
Pediatric cannabis exposures remain a critical public health concern, especially with high-potency edibles. Oregon's failed bill to limit THC in edibles highlights ongoing risks. Clinicians must counsel on safe storage and dosing to reduce accidental…
Endocannabinoid System Research: Cannabinoids in Pediatrics
Cannabinoids pediatric research is expanding with numerous studies examining safety and efficacy in children. This living systematic review highlights 276 studies across various pediatric conditions. Clinicians should consider this evolving evidence base…
Kids as Young as 11 Being Treated for Cannabis Use Disorder, Children’s National Hospital Says
Cannabis use disorder in children is an emerging concern requiring early screening and intervention. Children as young as 11 are being treated for this disorder. Understanding youth cannabis accessibility helps inform prevention strategies.
Medical Cannabis Evidence-Based Care: CBD Autism RCT
This CBD autism clinical trial investigated oral CBD oil effects on social behavior, anxiety, and parental stress in autistic children. The randomized controlled crossover design provided rigorous evidence. Results suggest potential benefits of CBD in…